The potential association between RECQL4 high amplification and the host immune response in cancer patients captured our interest, prompting us to compares intra‐tumoural immune cell infiltration across various RECQL4 CNA within the TCGA SKCM cohort. The gene discussed is RECQL4; the disease is cancer.